We have previously reported the establishment of a Staphylococcus aureus laboratory strain, 10*3d1, having reduced susceptibility to daptomycin and heterogeneous vancomycin-intermediate S. aureus (VISA) phenotype. The strain was generated in vitro by serial daptomycin selection (Camargo, I. L., H. M. Neoh, L. Cui, and K. Hiramatsu, Antimicrob. Agents Chemother. 52:4289-4299, 2008). Here we explored the genetic mechanism of resistance in the strain by whole-genome sequencing and by producing gene-replaced strains. By genome comparison between 10*3d1 and its parent methicillin-resistant Staphylococcus aureus (MRSA) strain N315ΔIP, we identified five nonsynonymous single nucleotide polymorphisms (SNPs). One of the five mutations was found in t...
<div><p>Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant <em>Staphyloc...
We obtained a series of methicillin-resistant Staphylococcus aureus isolates, including both daptomy...
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (...
Daptomycin is an extensively used anti-staphylococcal agent due to the rise in methicillin-resistant...
Two daptomycin (DAP) regimens were evaluated in a pharmacokinetic/pharmacodynamic (PK/PD) model, and...
Staphylococcus aureus is a major cause of nosocomial and community-acquired infections. The success ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Previous studies showed serial 20 d in vitro passage of MRSA strain MW2 in sublethal daptomycin (DAP...
Objectives The development of daptomycin resistance in Staphylococcus aureus is associated with clin...
The extensive use of daptomycin for treating complex methicillin-resistant Staphylococcus aureus inf...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to c...
clinical strains, 27 (71%) possessed a muta-tion(s) in rpoB encoding the -subunit of RNA polymerase....
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
<div><p>Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant <em>Staphyloc...
We obtained a series of methicillin-resistant Staphylococcus aureus isolates, including both daptomy...
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (...
Daptomycin is an extensively used anti-staphylococcal agent due to the rise in methicillin-resistant...
Two daptomycin (DAP) regimens were evaluated in a pharmacokinetic/pharmacodynamic (PK/PD) model, and...
Staphylococcus aureus is a major cause of nosocomial and community-acquired infections. The success ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Previous studies showed serial 20 d in vitro passage of MRSA strain MW2 in sublethal daptomycin (DAP...
Objectives The development of daptomycin resistance in Staphylococcus aureus is associated with clin...
The extensive use of daptomycin for treating complex methicillin-resistant Staphylococcus aureus inf...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to c...
clinical strains, 27 (71%) possessed a muta-tion(s) in rpoB encoding the -subunit of RNA polymerase....
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
<div><p>Glycopeptides are still the gold standard to treat MRSA (Methicillin Resistant <em>Staphyloc...
We obtained a series of methicillin-resistant Staphylococcus aureus isolates, including both daptomy...
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (...